{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:07:57Z","timestamp":1790485677258,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with nephrosclerosis display heterogenous clinical phenotypes, often leading to a clinical diagnosis discordant with pathological nephrosclerosis diagnosis. However, little is known about clinical factors associated with clinicopathological discordance of biopsy-proven nephrosclerosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a cross-sectional study of 891 patients with biopsy-proven nephrosclerosis registered in the Japan Renal Biopsy Registry (J-RBR) between July 2007 and June 2016, we examined clinical characteristics associated with a pre-biopsy clinical diagnosis discordant with pathological nephrosclerosis diagnosis using multivariable logistic regression with adjustment for relevant clinical characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, the mean (SD) age was 58.6 (13.7) years; 67.6% of patients were male; and 63.2% were on antihypertensive drugs. The median estimated glomerular filtration rate (eGFR) was 43.8\u00a0mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup> and the median proteinuria was 0.5\u00a0g\/day. Of the 891 patients, 497 (55.8%) had a clinical diagnosis discordant with pathological nephrosclerosis diagnosis, with chronic nephritic syndrome being the most common (&gt;\u200975%) discordant clinical diagnosis. After multivariable adjustment, age (odds ratio 1.34, [95% confidence interval, 1.16\u20131.55], per 10\u00a0years increase), eGFR (1.10 [1.00\u20131.21], per 10\u00a0mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup> increase), and proteinuria (1.20 [1.03\u20132.16], per 1\u00a0g\/day decrease) were found to be significantly associated with the clinicopathological discordance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with older age, higher eGFR, and lower proteinuria had significantly higher likelihood of being clinically diagnosed with other glomerular disease in patients with biopsy-proven nephrosclerosis. Our findings highlight the heterogeneous clinical phenotypes of nephrosclerosis and suggest the need for continuous improvement of clinical diagnostic accuracy as well as for wider kidney biopsy indications for nephrosclerosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10157-021-02161-1","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T16:51:52Z","timestamp":1637686312000},"page":"325-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinicopathological discordance in biopsy-proven nephrosclerosis: a nationwide cross-sectional study of the Japan Renal Biopsy Registry (J-RBR)"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5656-3609","authenticated-orcid":false,"given":"Keiichi","family":"Sumida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Furuichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Uesugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"issue":"1","key":"2161_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41100-020-00286-9","volume":"6","author":"K Nitta","year":"2020","unstructured":"Nitta K, Goto S, Masakane I, et al. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Replacement Therapy. 2020;6(1):41.","journal-title":"Renal Replacement Therapy"},{"issue":"3S1","key":"2161_CR2","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","volume":"73","author":"R Saran","year":"2019","unstructured":"Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73(3S1):A7\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2161_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/joim.13146","volume":"289","author":"SI Hallan","year":"2021","unstructured":"Hallan SI, Ovrehus MA, Bjorneklett R, Aasarod KI, Fogo AB, Ix JH. Hypertensive nephrosclerosis: wider kidney biopsy indications may be needed to improve diagnostics. J Intern Med. 2021;289(1):69\u201383.","journal-title":"J Intern Med"},{"issue":"3","key":"2161_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1753944715578596","volume":"9","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Kobayashi K, Ishida Y, et al. Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years\u2019 experience in a single, kidney disease center. Ther Adv Cardiovasc Dis. 2015;9(3):77\u201386.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"1","key":"2161_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147690","volume":"11","author":"K Sumida","year":"2016","unstructured":"Sumida K, Hoshino J, Ueno T, et al. Effect of proteinuria and glomerular filtration rate on renal outcome in patients with biopsy-proven benign nephrosclerosis. PLoS\u00a0One. 2016;11(1): e0147690.","journal-title":"PLoS\u00a0One"},{"issue":"2","key":"2161_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/jch.13818","volume":"22","author":"NR Robles","year":"2020","unstructured":"Robles NR, Fici F, Ari Bakir E, Grassi G. Does established vascular kidney disease exist? J Clin Hypertens (Greenwich). 2020;22(2):296\u20138.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"2161_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10157-017-1496-4","volume":"22","author":"K Furuichi","year":"2018","unstructured":"Furuichi K, Shimizu M, Yuzawa Y, et al. Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis. Clin Exp Nephrol. 2018;22(3):629\u201337.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"2161_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10157-011-0430-4","volume":"15","author":"H Sugiyama","year":"2011","unstructured":"Sugiyama H, Yokoyama H, Sato H, et al. Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol. 2011;15(4):493\u2013503.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"2161_CR9","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2161_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0272-6386(12)70275-5","volume":"23","author":"SD Schlessinger","year":"1994","unstructured":"Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis. 1994;23(5):655\u201360.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"2161_CR11","first-page":"679","volume":"10","author":"P Zucchelli","year":"1996","unstructured":"Zucchelli P, Zuccala A. Recent data on hypertension and progressive renal disease. J Hum Hypertens. 1996;10(10):679\u201382.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2161_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/ki.1997.29","volume":"51","author":"A Fogo","year":"1997","unstructured":"Fogo A, Breyer JA, Smith MC, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int. 1997;51(1):244\u201352.","journal-title":"Kidney Int"},{"issue":"11","key":"2161_CR13","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/ndt\/15.11.1801","volume":"15","author":"L Zarif","year":"2000","unstructured":"Zarif L, Covic A, Iyengar S, Sehgal AR, Sedor JR, Schelling JR. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. Nephrol Dial Transplant. 2000;15(11):1801\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2161_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/01.HYP.38.2.171","volume":"38","author":"ER Caetano","year":"2001","unstructured":"Caetano ER, Zatz R, Saldanha LB, Praxedes JN. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension. 2001;38(2):171\u20136.","journal-title":"Hypertension"},{"issue":"5","key":"2161_CR15","first-page":"391","volume":"34","author":"YS Guo","year":"2006","unstructured":"Guo YS, Yuan WJ, Yu JP, et al. Clinical and pathological characteristics in patients with clinically presumed hypertensive nephrosclerosis. Zhonghua Xin Xue Guan Bing Za Zhi. 2006;34(5):391\u20135.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"3","key":"2161_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ekir.2019.12.010","volume":"5","author":"MA Ovrehus","year":"2020","unstructured":"Ovrehus MA, Oldereid TS, Dadfar A, et al. Clinical phenotypes and long-term prognosis in White patients with biopsy-verified hypertensive nephrosclerosis. Kidney Int Rep. 2020;5(3):339\u201347.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"2161_CR17","first-page":"271","volume":"86","author":"A Innes","year":"1993","unstructured":"Innes A, Johnston PA, Morgan AG, Davison AM, Burden RP. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Q J Med. 1993;86(4):271\u20135.","journal-title":"Q J Med"},{"issue":"7","key":"2161_CR18","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/ndt\/gfy121","volume":"34","author":"M Yamanouchi","year":"2019","unstructured":"Yamanouchi M, Hoshino J, Ubara Y, et al. Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study. Nephrol Dial Transplant. 2019;34(7):1182\u20138.","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-021-02161-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T06:30:13Z","timestamp":1647498613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-021-02161-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2161"],"URL":"https:\/\/doi.org\/10.1007\/s10157-021-02161-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]},"assertion":[{"value":"14 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number: the Japanese Society of Nephrology, No. 41, December 14, 2016) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}